Read on Twitter
Live: Launch of the #COVID19 Technology Access Pool https://www.pscp.tv/w/cZ_KLDI2MTAyMHwxWXBLa1FCUE5uUEpqdpytEMJXNJNJJSeqkoix4L2nmErUAQiPHbeG5QRncI4=
"Since the beginning of the #COVID19 pandemic, science has been at the heart of WHO’s efforts to suppress transmission and save lives"- @DrTedros
"Science is moving with incredible speed. Almost every day there is more news about research into vaccines, diagnostics and therapeutics.
But will all people benefit from these tools? Or will they become another reason people are left behind?"- @DrTedros #COVID19
But will all people benefit from these tools? Or will they become another reason people are left behind?"- @DrTedros #COVID19
"A month ago, WHO and partners launched the ACT Accelerator, to speed up the development, production and equitable distribution of vaccines, diagnostics and therapeutics for #COVID19"- @DrTedros
"Today we are joining 35 countries and numerous partners to launch the #COVID19 Technology Access Pool, or C-TAP.
C-TAP was first proposed by President @CarlosAlvQ of #CostaRica, and I’d like to thank His Excellency the President for his leadership and solidarity"- @DrTedros
C-TAP was first proposed by President @CarlosAlvQ of #CostaRica, and I’d like to thank His Excellency the President for his leadership and solidarity"- @DrTedros
"C-TAP is a sister initiative of the ACT Accelerator and offers concrete actions to achieve the objective of the ACT Accelerator, which is equitable access"- @DrTedros #COVID19
"C-TAP has 
priorities:
public disclosure of gene sequencing research
public disclosure of all clinical trial results"- @DrTedros
#COVID19
priorities: public disclosure of gene sequencing research public disclosure of all clinical trial results"- @DrTedros #COVID19
"C-TAP has priorities:
encouraging govts & research funders to include clauses in contracts with pharmaceutical companies about equitable distribution & publication of trial data
licensing treatments and vaccines to large and small producers"- @DrTedros
#COVID19
priorities: encouraging govts & research funders to include clauses in contracts with pharmaceutical companies about equitable distribution & publication of trial data licensing treatments and vaccines to large and small producers"- @DrTedros #COVID19
"C-TAP has priorities:
promoting open innovation models and technology transfer that increase local manufacturing and supply capacity"- @DrTedros
#COVID19
priorities: promoting open innovation models and technology transfer that increase local manufacturing and supply capacity"- @DrTedros #COVID19
"Through C-TAP, we are inviting companies or governments that develop an effective therapeutic to contribute the patent to the Medicines Patent Pool, which would then sub-license the patent to generic manufacturers"- @DrTedros #COVID19
"C-TAP is voluntary, and builds on the success of the Medicines Patent Pool in expanding access to treatments for HIV and hepatitis C.
WHO recognizes the important role that patents play in fuelling innovation. But this is a time when people must take priority"- @DrTedros #COVID19
WHO recognizes the important role that patents play in fuelling innovation. But this is a time when people must take priority"- @DrTedros #COVID19
"Tools to prevent, detect and treat #COVID19 are global public goods that must be accessible by all people.
Science is giving us solutions, but to make those solutions work for everyone, we need solidarity"- @DrTedros
Science is giving us solutions, but to make those solutions work for everyone, we need solidarity"- @DrTedros
" #COVID19 has highlighted the inequalities of our world. But it’s also offering us an opportunity to bridge those inequalities and build a fairer world – a world in which health is not a privilege for the few, but a common good"- @DrTedros
